Saturday, May 2, 2015
- 5:30pm-7:30pm
-
Ideal Versus Total Body Weight Dosing of Rabbit Anti-Thymocyte Globulin Induction Therapy on Patient Outcomes in High Immunological Risk Kidney Transplant
Poster Session A: Kidney Immunosuppression: Induction Therapy • Exhibit Hall E
- 5:30pm-7:30pm
-
IL-17 Production Influenced by Induction Therapy With ATG
Poster Session A: Kidney Immunosuppression: Induction Therapy • Exhibit Hall E
- 5:30pm-7:30pm
-
IL-33 Enhances Host Tolerance to Candida albicans Kidney Infections Through Induction of IL-13 Production by CD4+ T Cells
Poster Session A: Preclinical Immunosuppression and Tolerance • Exhibit Hall E
- 5:30pm-7:30pm
-
ILC1 and ILC3 Are the Predominant Intra-Epithelial Lymphoid Populations in Human Small Bowel Grafts
Poster Session A: Small Bowel All Topics • Exhibit Hall E
- 5:30pm-7:30pm
-
Immune Response to Kidney and Pancreas Self-Antigens Are Associated With Antibody Mediated Rejection in Simultaneous Kidney Pancreas Transplants
Poster Session A: Kidney Antibody Mediated Rejection • Exhibit Hall E
- 5:30pm-7:30pm
-
Immune-Mediated Injury in Kidney Transplant Recipients Treated With Alemtuzumab Induction and a Steroid Avoidance Protocol
Poster Session A: Kidney Immunosuppression: Induction Therapy • Exhibit Hall E
- 5:30pm-7:30pm
-
Immunodeficiency Assessment in Pediatric Intestinal Failure Patients
Poster Session A: Small Bowel All Topics • Exhibit Hall E
- 5:30pm-7:30pm
-
Immunological Aspects of Iron Overload in Heart and Kidney Transplantation
Poster Session A: Acute Allograft Rejection • Exhibit Hall E
- 5:30pm-7:30pm
-
Immunomodulation of Human T Cells by a Novel RALG Preparation With Higher Specificity Toward Activating T Cells
Poster Session A: Preclinical Immunosuppression and Tolerance • Exhibit Hall E
- 5:30pm-7:30pm
-
Impact of HMOX1 Genetic Variation in Pancreas Transplant Recipients On Long-Term Graft Outcome
Poster Session A: Preclinical Immunosuppression and Tolerance • Exhibit Hall E
- «Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 30
- Next Page»